Paper41389337
One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy.
Cao X and 5 others. Cancer Metastasis Rev, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy. Papers, record 41389337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41389337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Carbon | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Animals | |
| Metabolic Networks and Pathways |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BYSY2022069 | Peking University Third Hospital Clinical Key Project | PubMed | ||
| BYSYZD2023010 | Peking University Third Hospital Clinical Key Project | PubMed | ||
| No. 82303801 | Youth Program of National Natural Science Foundation of China | PubMed | ||
| No. 82204678 | Youth Program of National Natural Science Foundation of China | PubMed | ||
| 2022YFA1104001 | the National Key Research and Development Program of China | PubMed | ||
| No.82272745 | National Natural Science Foundation of China | PubMed |
Source PubMed
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33142801 | BRCA1-A and BRISC: Multifunctional Molecular Machines for Ubiquitin Signaling. | Biomolecules | 2020 | https://conductscience.org/library/papers/33142801 | PubMed |
| 2 | 37108312 | SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108312 | PubMed |
| 3 | 23242140 | Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. | Nature | 2013 | https://conductscience.org/library/papers/23242140 | PubMed |
| 4 | 30534944 | Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications. | J Natl Cancer Inst | 2019 | https://conductscience.org/library/papers/30534944 | PubMed |
| 5 | 27264180 | Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow. | Cell Rep | 2016 | https://conductscience.org/library/papers/27264180 | PubMed |
| 6 | 30909399 | DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents. | Molecules | 2019 | https://conductscience.org/library/papers/30909399 | PubMed |
| 7 | 24075985 | A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. | Cell Rep | 2013 | https://conductscience.org/library/papers/24075985 | PubMed |
| 8 | 36380144 | Valemetostat Tosilate: First Approval. | Drugs | 2022 | https://conductscience.org/library/papers/36380144 | PubMed |
| 9 | 39818457 | Mechanisms and rationales of SAM homeostasis. | Trends Biochem Sci | 2025 | https://conductscience.org/library/papers/39818457 | PubMed |
| 10 | 39136771 | Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/39136771 | PubMed |
| 11 | 38848370 | Hydroxylamine production by Alcaligenes faecalis challenges the paradigm of heterotrophic nitrification. | Sci Adv | 2024 | https://conductscience.org/library/papers/38848370 | PubMed |
| 12 | 37875111 | Methotrexate-based PROTACs as DHFR-specific chemical probes. | Cell Chem Biol | 2024 | https://conductscience.org/library/papers/37875111 | PubMed |
| 13 | 34479957 | Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34479957 | PubMed |
| 14 | 26831078 | Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26831078 | PubMed |
| 15 | 9245423 | The homodimeric form of glycine N-methyltransferase acts as a polycyclic aromatic hydrocarbon-binding receptor. | Biochemistry | 1997 | https://conductscience.org/library/papers/9245423 | PubMed |
| 16 | 32436060 | A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/32436060 | PubMed |
| 17 | 30744688 | Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30744688 | PubMed |
| 18 | 31607565 | Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation. | Cell Metab | 2019 | https://conductscience.org/library/papers/31607565 | PubMed |
| 19 | 34244426 | p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34244426 | PubMed |
| 20 | 30365149 | I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3. | Oncol Rep | 2019 | https://conductscience.org/library/papers/30365149 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793024 | The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42793024 | PubMed |
| 42640410 | Integrated Multi-Omics Analysis of Gut Microbiota-Associated Metabolites and Related Host Molecular Signatures in Cervical Squamous Cell Carcinoma. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42640410 | PubMed |
| 42516378 | One-carbon metabolism in cancer immunity: T-cell fitness, epigenetic programming, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42516378 | PubMed |
| 42417838 | RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42417838 | PubMed |
| 42357368 | Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357368 | PubMed |
| 41899603 | Crosstalk Between Cis-Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899603 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41389337
GET https://conductscience.org/api/papers/v1/41389337/references?page=2